Interphex
DDL Launches New GMP Lab for Drug-Delivery Testing
New 10,600 sq.-ft. GMP lab will offer ICH stability testing, functional and mechanical performance testing and simulated distribution testing.
DDL, a provider of package, product, and material testing services, has opened a new Good Manufacturing Practice (GMP) lab dedicated to drug-device combination product testing. This expansion enhances DDL’s capacity to support the pharmaceutical, biotech and combination product industries with regulatory-compliant testing solutions.
The new FDA registered 10,600 sq.-ft. GMP lab is located near DDL’s Eden Prairie, MN headquarters. The lab will offer ICH stability testing, functional and mechanical performance testing (ISO 11040 & ISO 11608) and simulated distribution testing to meet the growing demand for high-quality GMP testing for devices such as auto injectors, pre-filled syringes, inhalers, and other combination products. With state-of-the-art equipment and an experienced team of engineers, DDL’s new facility will provide comprehensive testing services in accordance with FDA, ISO, and other global regulatory standards.
“We are excited to expand our testing footprint with this new GMP laboratory, reinforcing our commitment to providing high-quality, reliable testing services to our medical device and pharmaceutical clients,” said Aaron Liss, Director of Sales & Marketing, DDL, Inc. “This new GMP offering builds upon our 35 years of industry experience allowing DDL to collaborate with an entirely new host of healthcare providers.”
DDL will be highlighting its GMP testing capabilities, as well as its package, medical device and material testing service offerings in Booth 1143 at the Interphex.
